![OSE Immunotherapeutics SA logo](/logos/OSE.PA.webp)
OSE Immunotherapeutics SA
EPA:OSE.PA
Overview | Financials
Company Name | OSE Immunotherapeutics SA |
Symbol | OSE.PA |
Currency | EUR |
Price | 8.51 |
Market Cap | 185,120,617 |
Dividend Yield | 0% |
52-week-range | 3.025 - 8.9 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Nicolas Poirier Ph.D. |
Website | https://www.ose-immuno.com |
An error occurred while fetching data.
About OSE Immunotherapeutics SA
OSE Immunotherapeutics SA focuses on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. Its products include Tedopi that is in Phase III clinical stage for the treatment of non-small cell lung cancer, as well as in Phase II clinical trial to
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD